stars 1 stars 2 stars 3

Exiris is a preclinical stage company that uses a unique combination of technology platforms to discover novel oncology targets and to generate innovative therapeutic agents for the treatment of oncology indications with high unmet medical need.

Exiris s.r.l. Questions

The Exiris s.r.l. annual revenue was $4 million in 2026.

Gessica Filocamo is the Director of Cell Biology of Exiris s.r.l..

3 people are employed at Exiris s.r.l..

Exiris s.r.l. is based in Rome, Latium.

The NAICS codes for Exiris s.r.l. are [541, 54, 5417, 541714, 54171].

The SIC codes for Exiris s.r.l. are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users